Experience

Sandhya Deo

    • Manage the global patent portfolio of Usher III Initiative 


    • Obtained the first US patents covering combination HIV therapies for Gilead Sciences 


    • Vascular Biogenics Prices IPO 


    • Vitae Pharmaceuticals Completes Initial Public Offering  


    • Flexion $74 Million Initial Public Offering 


    • Cooley Advised Flexion on Initial Public Offering 


    • Cara Therapeutics $55 Million Initial Public Offering 


    • First US IPO of 2014 for GlycoMimetics